» Articles » PMID: 20721574

The Clinical Spectrum of Late-onset Alexander Disease: a Systematic Literature Review

Overview
Journal J Neurol
Specialty Neurology
Date 2010 Aug 20
PMID 20721574
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Following the discovery of glial fibrillary acidic protein (GFAP) mutations as the causative factor of Alexander disease (AxD), new case reports have recently increased, prompting a more detailed comprehension of the clinical features of the three disease subtypes (infantile, juvenile and adult). While the clinical pattern of the infantile form has been substantially confirmed, the late-onset subtypes (i.e., juvenile and adult), once considered rare manifestations of AxD, have displayed a wider clinical spectrum. Our aim was to evaluate the clinical phenotype of the adult and juvenile forms by reviewing the previously reported cases. Data were collected from previously published reports on 112 subjects affected by neuropathologically or genetically proven adult and juvenile Alexander disease. Although the late-onset forms of AxD show a wide clinical variability, a common pattern emerges from comparing previously reported cases, characterized by pseudo-bulbar signs, ataxia, and spasticity, associated with atrophy of the medulla and upper cervical cord on neuroimaging. Late-onset AxD cases can no longer be considered as rare manifestations of the disease. The clinical pattern usually reflects the topographic localization of the lesions, with adult cases displaying a predominant infratentorial localization of the lesions. Juvenile cases show clinical and radiological features which are intermediate between adult and infantile forms.

Citing Articles

Teenager With Recurrent Ataxia, Ophthalmoplegia, and Encephalopathy Associated With Demyelination: From the National Multiple Sclerosis Society Case Conference Proceedings.

Poisson K, Newsome S, Graves J, Zamvil S, Marcus L Neurol Neuroimmunol Neuroinflamm. 2024; 11(2):e200193.

PMID: 38181318 PMC: 11078149. DOI: 10.1212/NXI.0000000000200193.


Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions.

Muthusamy K, Sivadasan A, Dixon L, Sudhakar S, Thomas M, Danda S Front Neurol. 2023; 14:1219324.

PMID: 37564735 PMC: 10410460. DOI: 10.3389/fneur.2023.1219324.


Genetic spectrum and clinical features of adult leukoencephalopathies in a Chinese cohort.

Liu M, Wang Y, Shi C, Yuan Y, Li L, Zhang X Ann Clin Transl Neurol. 2023; 10(7):1119-1135.

PMID: 37237429 PMC: 10351660. DOI: 10.1002/acn3.51794.


Alexander disease: the road ahead.

Pajares M, Hernandez-Gerez E, Pekny M, Perez-Sala D Neural Regen Res. 2023; 18(10):2156-2160.

PMID: 37056123 PMC: 10328293. DOI: 10.4103/1673-5374.369097.


Psychiatric Onset Alexander Disease: An Important Challenge in Neuropsychiatric Diagnosis: A Case Report.

Arshiany H, Ezzatian B, Artounian V, Alizadeh F, Mohammadian F Basic Clin Neurosci. 2022; 13(2):269-274.

PMID: 36425948 PMC: 9682316. DOI: 10.32598/bcn.2021.1551.1.


References
1.
Balbi P, Seri M, Ceccherini I, Uggetti C, Casale R, Fundaro C . Adult-onset Alexander disease : report on a family. J Neurol. 2007; 255(1):24-30. DOI: 10.1007/s00415-007-0654-0. View

2.
Crome L . Megalencephaly associated with hyaline pan-neuropathy. Brain. 1953; 76(2):215-28. DOI: 10.1093/brain/76.2.215. View

3.
Messing A, Brenner M . Alexander disease: GFAP mutations unify young and old. Lancet Neurol. 2003; 2(2):75. DOI: 10.1016/s1474-4422(03)00301-6. View

4.
van der Knaap M, Naidu S, Breiter S, Blaser S, Stroink H, Springer S . Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol. 2001; 22(3):541-52. PMC: 7976831. View

5.
Brockmann K, Meins M, Taubert A, Trappe R, Grond M, Hanefeld F . A novel GFAP mutation and disseminated white matter lesions: adult Alexander disease?. Eur Neurol. 2003; 50(2):100-5. DOI: 10.1159/000072507. View